Page last updated: 2024-09-04

alpha-ergocryptine and sulpiride

alpha-ergocryptine has been researched along with sulpiride in 1 studies

Compound Research Comparison

Studies
(alpha-ergocryptine)
Trials
(alpha-ergocryptine)
Recent Studies (post-2010)
(alpha-ergocryptine)
Studies
(sulpiride)
Trials
(sulpiride)
Recent Studies (post-2010) (sulpiride)
74184,152427635

Protein Interaction Comparison

ProteinTaxonomyalpha-ergocryptine (IC50)sulpiride (IC50)
Carbonic anhydrase 1Homo sapiens (human)1.2
Carbonic anhydrase 2Homo sapiens (human)0.04
Alpha-2A adrenergic receptorHomo sapiens (human)2.019
D(2) dopamine receptorHomo sapiens (human)0.0858
D(3) dopamine receptorHomo sapiens (human)0.2651
D(2) dopamine receptorRattus norvegicus (Norway rat)0.2215
Carbonic anhydrase 4Bos taurus (cattle)0.62
D(2) dopamine receptorCanis lupus familiaris (dog)0.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birrenkott, GP; Cross, DL; Grimes, LW; Strickland, JR1

Other Studies

1 other study(ies) available for alpha-ergocryptine and sulpiride

ArticleYear
Effect of ergovaline, loline, and dopamine antagonists on rat pituitary cell prolactin release in vitro.
    American journal of veterinary research, 1994, Volume: 55, Issue:5

    Topics: Alkaloids; Animals; Cells, Cultured; Domperidone; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Ergotamines; Male; Pituitary Gland; Prolactin; Radioimmunoassay; Rats; Rats, Wistar; Sulpiride; Vasoconstrictor Agents

1994